Table 2.
Putative pathomechanisms | Putative therapeutic agents | Species | Sources |
---|---|---|---|
Oxidative Stress |
N-Acetylcystein Atorvastatin Montelukast |
Mouse, rat | |
Renin–angiotensin–aldosterone system (RAAS) |
ACE-inhibitors Aldosterone-antagonists |
Human, mouse, rat | [76–82] |
Cellular senescence (CS) | Rat | [83] | |
Inflammation | Montelukast | Mouse, tibet mini pigs, rabbits, primates | |
Fibrosis |
ACE-inhibitors Epoxyeicosatrienoic acids |
Human Mouse, primates |
[76] |
Vascular dysfunction | Epoxyeicosatrienoic acids | Human, mouse, rat | [88–91] |